This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Novartis spun out the testing and development of abelacimab and formed Anthos Therapeutics back in 2019. Bayer terminated its OCEANIC-AF trial for its Factor XI inhibitor, asundexian, due to 3x greater stroke (1.3% vs. 0.4%) and 4x higher ischemic stroke rates (csHR = 4.06).
Systematic search conducted without language restrictions from December 1, 2019 to June 31, 2022 on PubMed, EMBASE, Web of Science, Cochrane library, ProQuest Coronavirus Research Database, COVID-19 Living Overview of the Evidence (L-OVE) subset of Episteminokos and the World Health Organization (WHO) Covid-19 databases.
Findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial were presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, being held through Feb. A lot of our approaches in stroke treatment were learned from how we treat heart attacks.
7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. 7-9, and is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health. The meeting will be held in Phoenix, Feb. The meeting will be held in Phoenix, Feb.
Stroke, Volume 56, Issue 1 , Page 113-121, January 1, 2025. BACKGROUND:Physical activity is an effective modifiable behavior for preventing recurrent strokes. This study aims to determine the adherence to physical activity recommendations among stroke survivors in the United States. versus 62.3%;P<0.0001). versus 67.9%;P<0.0001];
Stroke, Volume 55, Issue Suppl_1 , Page ATMP98-ATMP98, February 1, 2024. Introduction:Functional outcomes after acute stroke (AS) are related to the initial neurological severity. We defined MNS as a score of ≤5 points on the National Institutes of Health Stroke Scale.
Stroke, Ahead of Print. BACKGROUND:Stroke triggers are factors that may precipitate a stroke within a given time interval and can predict the timing of a stroke. More research is needed to assess the link between the severity of hypoglycemia and stroke occurrence, as well as the severity of the stroke.
BACKGROUND:Cardiovascular disease and stroke are common and costly, and their prevalence is rising. to 3.8%), stroke (3.9% Circulation, Ahead of Print. in 2020 to 61.0% The prevalences of poor diet, inadequate physical activity, and smoking are estimated to improve over time, whereas inadequate sleep will worsen. to 15.0%) will rise.
Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. This irregular heartbeat is associated with increased risks of heart failure, dementia and stroke. It constitutes a significant burden to healthcare systems, making its early detection and treatment a major goal.
Stroke, Volume 55, Issue Suppl_1 , Page AWP235-AWP235, February 1, 2024. Introduction:Amid the rising prevalence of cannabis use disorder (CUD) in older adults and with surveys reporting ~85% of overlapping use for medicinal and recreational purposes in American cannabis users, the link between CUD and stroke is paramount. vs. 28.4%).
Stroke, Volume 55, Issue Suppl_1 , Page A13-A13, February 1, 2024. Elderly obese stroke survivors (> 65 years) having a recurrent acute ischemic stroke (AIS), with or without prior bariatric surgery (PBS), were identified using ICD-10 codes. Both groups (PBS vs. no PBS) were predominantly female (59.7% vs. 90.7%).
Stroke, Volume 55, Issue Suppl_1 , Page ATP120-ATP120, February 1, 2024. Background:Racial disparities in stroke prevalence and outcomes have been well documented in previous studies, but there is not sufficient data based on post-menopausal women. Demographics were analyzed after stratifying the population by race. were white, 16.5%
MethodsSix centers in China participated in this prospective, multicenter study of PFO closure from June 2019 to September 2020. Except for 2 cases (1.4%) of micropericardial effusion, there were no other complications such as cardiac tamponade, major bleeding, stroke oroccluder embolization. The procedural success rate was 99.3%.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP100-ATMP100, February 1, 2024. Introduction:Rising obesity rates and the increasing prevalence of stroke in the metabolically healthy obese (MHO) necessitate examining its association in younger (18-44 year) populations.
This underuse of anticoagulants for stroke prevention has been cited as one of the greatest public health issues facing cardiovascular patients 6. Many doctors are put in the unfortunate position of having to weigh the risk of stroke against the risk of bleeding for their patients with AFib, said Christian T. Nat Rev Cardiol.
Stroke, Ahead of Print. BACKGROUND:Obtaining timely informed consent is a key barrier in acute ischemic stroke clinical trial recruitment. eConsent in acute ischemic stroke clinical trials, however, is limited and understudied. eConsent in acute ischemic stroke clinical trials, however, is limited and understudied.
Stroke, Volume 56, Issue Suppl_1 , Page ATP62-ATP62, February 1, 2025. Introduction:Education for post-acute stroke patients is crucial for several reasons: recovery and rehabilitation, prevention of recurrence, empowerment, caregiver support, and health literacy. The data for 2023 reflects a continuation of this positive trend.
Stroke, Volume 56, Issue Suppl_1 , Page ATP136-ATP136, February 1, 2025. Once these post-stroke patients have been identified, they are given a personalized monitoring plan depending on the individuals risk factors, the personalized care and rehabilitation plans are tracked and followed.
Stroke, Volume 56, Issue Suppl_1 , Page ATP270-ATP270, February 1, 2025. Introduction:Syphilis is associated with increased risk of cerebrovascular disease and acute stroke; stroke may even be the initial clinical manifestation of syphilis (Images 1 and 2). between 2016-2019, but then dropped to 1.02% in 2020.
Stroke, Volume 55, Issue Suppl_1 , Page AHUP16-AHUP16, February 1, 2024. Introduction:Recent reports demonstrate that stroke prevalence is expanding in young women, especially in diverse populations. In the total population, 25% had an intracerebral hemorrhage, 56% had an ischemic stroke, and 19% had a subarachnoid hemorrhage.
Stroke, Volume 55, Issue Suppl_1 , Page A35-A35, February 1, 2024. The University of Minnesota partnered with the M Health Fairview (MHFV) System to incorporate stroke clinical trials into the annual comprehensive stroke education courses.
Stroke, Volume 55, Issue Suppl_1 , Page A72-A72, February 1, 2024. Introduction:Associations between stroke subtype and post-stroke cognitive decline are unclear. Of the ischemic strokes, 22% were small-vessel occlusion, 8% large artery atherosclerosis, 21% cardioembolic, and 49% cryptogenic/other determined etiology.
Stroke, Volume 56, Issue Suppl_1 , Page A122-A122, February 1, 2025. Introduction:Standardized stroke response protocols have been shown to reduce Door to Puncture (DTP) times for Acute Ischemic Strokes (AIS), potentially improving functional outcomes and reducing mortality. This reduction time is equivalent to 22.8
Stroke, Volume 56, Issue Suppl_1 , Page AWP268-AWP268, February 1, 2025. Introduction:The overall composition of stroke subtype is typically stable within biogeographical groups. Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP21-ATMP21, February 1, 2024. Background:Medical comorbidities and stroke risk factors explain only a proportion of stroke incidence and outcomes in different populations. The primary outcome measure was discharge to home.
Stroke, Volume 55, Issue Suppl_1 , Page AWP263-AWP263, February 1, 2024. The concentration of equol was measured using liquid chromatography-mass spectrometry.Results:Eighty-five patients with stroke (43.5%) and 50 healthy subjects (48.5%) were equol producers (p=0.32). p=0.04) among patients with ischemic stroke.
Stroke, Volume 55, Issue Suppl_1 , Page A45-A45, February 1, 2024. Introduction:Telestroke enables timely and remote evaluation of patients with acute stroke syndromes. However, stroke mimics represent more than 30% of this population. To predict stroke mimic, TS had the highest AUC (68.3)
Stroke, Volume 55, Issue Suppl_1 , Page AWMP41-AWMP41, February 1, 2024. Introduction:High-quality prehospital care during initial assessment by EMS providers can affect downstream care for acute stroke patients. Stroke scale assessment was documented in 78% of cases, and blood glucose in 88%.
Stroke, Volume 56, Issue Suppl_1 , Page AWP104-AWP104, February 1, 2025. Background:Previous findings have shown high mobile stroke unit (MSU) call density scattered across a coverage area. Our MSU is operational from 0700-1900 and is dispatched for all 911 calls designated as probable or definite strokes.
Stroke, Volume 56, Issue Suppl_1 , Page ADP52-ADP52, February 1, 2025. Background:Physical activity is an effective modifiable behavior for preventing recurrent strokes. This study aims to determine the adherence to physical activity recommendations among stroke survivors in the United States. 62.3%; p<0.0001).
Stroke, Volume 56, Issue Suppl_1 , Page AWMP34-AWMP34, February 1, 2025. Introduction:Pediatric stroke, while one of the top 10 causes of mortality among U.S. We also identified all out-of-hospital strokes admitted to CHOC (ICD-10 search of discharge diagnoses) and determined the proportion of strokes presenting via EMS.
Stroke, Volume 56, Issue Suppl_1 , Page AWP96-AWP96, February 1, 2025. Our MSU is operational from 0700-1900 and is dispatched for all 911 calls designated as probable or definite strokes. We retrospectively reviewed all MSU calls from June 2019 to December 2023. and included all confirmed stroke patients in this analysis.
Stroke, Volume 56, Issue Suppl_1 , Page ATP139-ATP139, February 1, 2025. The stepped-wedge trial ran from May 2019 to January 2024 across three implementation waves. Findings provide a roadmap for healthcare systems implementing similar interventions, emphasizing leadership, coordinated care, and robust tracking for program success.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. A prior published analysis of national trends after one year in mechanical thrombectomy use and outcomes for stroke before and after publication of the 2015 US guideline update showed improved functional outcomes and lower peri‐procedural mortality.
Stroke, Volume 54, Issue 12 , Page 3128-3137, December 1, 2023. BACKGROUND:Both social service resources and stroke prevalence vary by geography, and health care resources are scarcer in rural areas. Models were sequentially adjusted for total population and CT demographics.RESULTS:In Ohio, stroke prevalence was 3.9% (0.4%–14.2%).
BackgroundPrevious clinical trials found improved outcome of thrombolytic treatment in patients with ischemic wake‐up stroke (WUS) selected by advanced imaging techniques. Thrombolytic treatment in WUS versus known‐onset stroke was compared in 730 patients (365 matched pairs). of patients with known‐onset stroke (OR, 1.14 [95% CI, 0.54–2.41];P=0.726).ConclusionsThrombolytic
Stroke, Volume 55, Issue Suppl_1 , Page AWP203-AWP203, February 1, 2024. A total of 4353 patients who underwent endovascular treatment for acute ischemic stroke between January 2016 and December 2020 were included in the study.
Stroke, Volume 55, Issue Suppl_1 , Page AWP17-AWP17, February 1, 2024. Introduction:The launch of AHA’s Target: Stroke Phase III in 2019 challenged stroke centers to achieve DTN times ≤ 30 min of arrival to ≥ 50% of AIS patients treated with IV thrombolytics.
Stroke, Volume 56, Issue Suppl_1 , Page AWP303-AWP303, February 1, 2025. Introduction:Significant strides have been made in optimizing thrombolysis and thrombectomy for acute ischemic stroke treatment. Prolonged arrival time was defined as more than 6 hours from the approximate last known well time.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP19-ATMP19, February 1, 2024. This study investigates factors influencing anxiety and depression prevalence in stroke patients.Methods:Utilizing 2019 National Health Interview Survey (NHIS) data, we conducted chi-square tests and multivariate logistic regression models, adjusting for various factors.
Stroke, Volume 55, Issue Suppl_1 , Page A43-A43, February 1, 2024. hours of ischemic stroke onset from 2003 to 2021. hours of ischemic stroke onset from 2003 to 2021. Thrombolysis rates and speed of treatment during TS phase I (2010-2013), II (2014-2018), and III (2019-2021) were compared with the pre-TS period (2003-2009).Results:Among
Stroke, Volume 55, Issue Suppl_1 , Page AWP49-AWP49, February 1, 2024. The Neuroscience Nurse Navigator Program [NNN-P], implemented December 2019, included SP who received Alteplase [IV-A] or Mechanical Thrombectomy [MT]. SP satisfaction [SP-S] assessed via paper tool changed to Press Ganey in 2021.Purpose:Evaluate
Stroke, Volume 56, Issue Suppl_1 , Page AWMP26-AWMP26, February 1, 2025. Introduction:Several pre-hospital scales predict ischemic stroke due to large vessel occlusion; however, these scales often fail to detect atypical endovascular thrombectomy (EVT) cases, including posterior circulation and distal vessel occlusion.
about 12 infants in 1,000 births have a congenital heart defect, according to the Associations 2025 Heart Disease and Stroke Statistics. million live births from the Korean National Health Insurance Service database from 2005 to 2019. In the U.S., Researchers analyzed health information about more than 3.5
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content